Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 7862
Gene Symbol: BRPF1
BRPF1
0.010 Biomarker disease BEFREE Here, we found that truncated BRPF1 protein, as found in human adult patients, is able to induce medulloblastoma in adult mice upon SmoM2 activation. 31851932 2019
Entrez Id: 2735
Gene Symbol: GLI1
GLI1
0.100 AlteredExpression disease BEFREE We found that FGFR signaling represses GLI1 expression downstream of activated SMO in the SHH MB line DAOY and induces <i>MKI67</i>, <i>HES1</i>, and <i>BMI1</i> in DAOY and in the group 3 MB line HD-MBO3. 31835472 2019
Entrez Id: 6608
Gene Symbol: SMO
SMO
0.690 GeneticVariation disease BEFREE Medulloblastoma in a Patient with Curry-Jones Syndrome with a mosaic variant, c.1234C > T (p.Leu412Phe), in SMO. 31825089 2020
Entrez Id: 7161
Gene Symbol: TP73
TP73
0.050 Biomarker disease BEFREE Previous studies have shown that P73 antisense RNA 1T (non-protein coding), also known as TP73-AS1, is a long non-coding RNA (lncRNA) and involved in the development of medulloblastoma. 31819485 2019
Entrez Id: 574452
Gene Symbol: MIR494
MIR494
0.030 Biomarker disease BEFREE The knockdown of TP73-AS1 inhibited cell proliferation, invasion, migration, and promoted apoptosis of medulloblastoma cells, while the miR-494-3p inhibitor abolished the effects of TP73-AS1 knockdown on medulloblastoma cells. 31819485 2019
Entrez Id: 83478
Gene Symbol: ARHGAP24
ARHGAP24
0.030 Biomarker disease BEFREE Previous studies have shown that P73 antisense RNA 1T (non-protein coding), also known as TP73-AS1, is a long non-coding RNA (lncRNA) and involved in the development of medulloblastoma. 31819485 2019
Entrez Id: 57212
Gene Symbol: TP73-AS1
TP73-AS1
0.020 Biomarker disease BEFREE The knockdown of TP73-AS1 inhibited cell proliferation, invasion, migration, and promoted apoptosis of medulloblastoma cells, while the miR-494-3p inhibitor abolished the effects of TP73-AS1 knockdown on medulloblastoma cells. 31819485 2019
Entrez Id: 6469
Gene Symbol: SHH
SHH
0.100 GeneticVariation disease BEFREE About 30% of patients experience relapse after treatment, possibly because of our inability to identify and eliminate the cancer stem cells.Zhang et al. recently investigated these cells in the SHH subgroup of medulloblastoma and identified drugs that may target them. 31813451 2019
Entrez Id: 6469
Gene Symbol: SHH
SHH
0.100 GeneticVariation disease BEFREE Herein, we review the main clinical and molecular features of the four consensus subgroups of MB (WNT, SHH, Group 3 and Group 4). 31799776 2019
Entrez Id: 4613
Gene Symbol: MYCN
MYCN
0.500 Biomarker disease BEFREE Here we generate humanized models for Sonic Hedgehog (SHH)-subgroup MB via MYCN overexpression in primary human hindbrain-derived neuroepithelial stem (hbNES) cells or iPSC-derived NES cells, which display a range of aggressive phenotypes upon xenografting. iPSC-derived NES tumors develop quickly with leptomeningeal dissemination, whereas hbNES-derived cells exhibit delayed tumor formation with less dissemination. 31786016 2019
Entrez Id: 643911
Gene Symbol: CRNDE
CRNDE
0.020 AlteredExpression disease BEFREE The in vivo role of CRNDE knockdown or miR-29c-3p overexpression on tumor growth and apoptosis was evaluated in a xenograft mouse model of human medulloblastoma. 31753063 2020
Entrez Id: 407026
Gene Symbol: MIR29C
MIR29C
0.010 Biomarker disease BEFREE RNA pull-down and RNA binding protein immunoprecipitation (RIP) were performed to confirm the molecular interactions between CRNDE and miR-29c-3p involved in medulloblastoma cells. 31753063 2020
Entrez Id: 1382
Gene Symbol: CRABP2
CRABP2
0.020 Biomarker disease BEFREE The human medulloblastoma UW228-2 cell line was cited as the control of CRABP2 methylation and gemcitabine as the demethylator control. 31736873 2019
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.030 AlteredExpression disease BEFREE TAA, as the essential components of disseminated tumor, produced high level of CCL2 to shape inflammation microenvironment, which stimulated the enrichment of MBSCs in disseminated MB. 31729527 2019
Entrez Id: 4760
Gene Symbol: NEUROD1
NEUROD1
0.030 Biomarker disease BEFREE NeuroD1 is involved in neuroblastoma and medulloblastoma; however, its molecular mechanism in promoting tumorigenesis remains unclear. 31715070 2020
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.400 Biomarker disease BEFREE Expression and association between PRMT5 and MYC in primary medulloblastoma tumors were investigated using publicly available databases. 31694585 2019
Entrez Id: 10419
Gene Symbol: PRMT5
PRMT5
0.010 Biomarker disease BEFREE In vitro therapeutic potential of PRMT5 in medulloblastoma was also evaluated using a small molecule inhibitor, EPZ015666. 31694585 2019
Entrez Id: 10278
Gene Symbol: EFS
EFS
0.010 GeneticVariation disease BEFREE To compare results from a third (1995-2010) cohort of children with medulloblastoma with two previous series (J Neurosurg 86:13-21, 1997; Arch Dis Child 54:200-203, 1979) to analyse the effects of management changes aimed at improving both overall and event-free survivals (OS and EFS) and functional outcomes. 31686139 2019
Entrez Id: 283219
Gene Symbol: KCTD21
KCTD21
0.020 AlteredExpression disease BEFREE KCTD15 inhibits the Hedgehog pathway in Medulloblastoma cells by increasing protein levels of the oncosuppressor KCASH2. 31685809 2019
Entrez Id: 79047
Gene Symbol: KCTD15
KCTD15
0.010 Biomarker disease BEFREE Here we report the identification of KCTD15 as a novel player in the complex network of regulatory proteins, which modulate Hh pathway, this could be a promising new target for therapeutic approach against MB. 31685809 2019
Entrez Id: 6774
Gene Symbol: STAT3
STAT3
0.400 Biomarker disease BEFREE Together these data identify STAT3 as a key molecule underpinning the sexual dimorphism in medulloblastoma. 31683879 2019
Entrez Id: 2146
Gene Symbol: EZH2
EZH2
0.100 Biomarker disease BEFREE Correction: EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway. 31676871 2020
Entrez Id: 836
Gene Symbol: CASP3
CASP3
0.030 AlteredExpression disease BEFREE Phosphorylated CHK1 serine 345 (pCHK1 S345), phosphorylated Histone 2A variant (γ-H2AX), and cleaved caspase-3 were quantified in mouse G3MB tumor tissues by immunohistochemistry at different time points up to 24 h post-dose. 31669383 2020
Entrez Id: 1111
Gene Symbol: CHEK1
CHEK1
0.020 Biomarker disease BEFREE CNS penetration and pharmacodynamics of the CHK1 inhibitor prexasertib in a mouse Group 3 medulloblastoma model. 31669383 2020
Entrez Id: 3014
Gene Symbol: H2AX
H2AX
0.020 Biomarker disease BEFREE Phosphorylated CHK1 serine 345 (pCHK1 S345), phosphorylated Histone 2A variant (γ-H2AX), and cleaved caspase-3 were quantified in mouse G3MB tumor tissues by immunohistochemistry at different time points up to 24 h post-dose. 31669383 2020